GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $228,000 | +0.4% | 5,230 | +1.8% | 0.07% | -4.0% |
| Q4 2021 | $227,000 | -11.7% | 5,138 | -23.6% | 0.08% | -21.1% |
| Q3 2021 | $257,000 | -7.9% | 6,723 | -4.1% | 0.10% | -2.1% |
| Q2 2021 | $279,000 | -15.2% | 7,013 | -24.0% | 0.10% | +3.2% |
| Q1 2021 | $329,000 | -2.7% | 9,228 | +0.5% | 0.09% | -10.5% |
| Q4 2020 | $338,000 | +56.5% | 9,179 | +75.4% | 0.10% | -35.6% |
| Q3 2020 | $216,000 | 0.0% | 5,232 | 0.0% | 0.16% | 0.0% |
| Q1 2020 | $216,000 | -15.6% | 5,232 | -3.8% | 0.16% | -20.1% |
| Q4 2019 | $256,000 | +18.5% | 5,438 | +3.9% | 0.20% | +25.2% |
| Q3 2019 | $216,000 | +4.3% | 5,232 | +1.1% | 0.16% | -9.9% |
| Q2 2019 | $207,000 | -2.4% | 5,175 | +1.8% | 0.18% | -7.7% |
| Q1 2019 | $212,000 | – | 5,083 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |